-
Alexopoulou L, Holt A C, Medzhitov R. Recognition of double-stranded rna and activation of nf-kappab by toll-like receptor 3[J]. Nature, 2001, 413(6857): 732-738. doi: 10.1038/35099560
-
Baer G M. The effect of interferon on rabies infection of animals[J]. Tex Rep Biol Med, 1981, 41(): 526-531.
-
Belshe R B, Mendelman P M, Treanor J. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children[J]. N Engl J Med, 1998, 338(20): 1405-1412. doi: 10.1056/NEJM199805143382002
-
Bradney C P, Sempowski G D, Liao H X. Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin g (igg) and iga antibodies in serum and mucosal secretions after nasal immunization[J]. J Virol, 2002, 76(2): 517-524. doi: 10.1128/JVI.76.2.517-524.2002
-
Burns J W, Siadat-Pajouh M, Krishnaney A A. Protective effect of rotavirus vp6-specific iga monoclonal antibodies that lack neutralizing activity[J]. Science, 1996, 272(5258): 104-107. doi: 10.1126/science.272.5258.104
-
Champney K J, Levine D P, Levy H B. Modified polyriboinosinic-polyribocytidylic acid complex: Sustained interferonemia and its physiological associates in humans[J]. Infect Immun, 1979, 25(3): 831-837.
-
Czerkinsky C, Anjuere F, Mcghee J R. Mucosal immunity and tolerance: Relevance to vaccine development[J]. Immunol Rev, 1999, 170(): 197-222. doi: 10.1111/imr.1999.170.issue-1
-
Fouchier R A, Kuiken T, Schutten M. Aetiology: Koch's postulates fulfilled for sars virus[J]. Nature, 2003, 423(6937): 240-. doi: 10.1038/423240a
-
Gai W, Zou W, Lei L. Effects of different immunization protocols and adjuvant on antibody responses to inactivated sars-cov vaccine[J]. Viral Immunol, 2008, 21(1): 27-37. doi: 10.1089/vim.2007.0079
-
Herman R, Baron S. Immunologic-mediated protection of trypanosoma congolense-infected mice by polyribonucleotides[J]. J Protozool, 1971, 18(4): 661-666. doi: 10.1111/jeu.1971.18.issue-4
-
Ichinohe T, Watanabe I, Ito S. Synthetic double-stranded rna poly(i:C) combined with mucosal vaccine protects against influenza virus infection[J]. J Virol, 2005, 79(5): 2910-2919. doi: 10.1128/JVI.79.5.2910-2919.2005
-
Jacobs B L, Langland J O. When two strands are better than one: The mediators and modulators of the cellular responses to double-stranded rna[J]. Virology, 1996, 219(2): 339-349. doi: 10.1006/viro.1996.0259
-
Kang S M, Compans R W. Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virus[J]. J Virol, 2003, 77(6): 3615-3623. doi: 10.1128/JVI.77.6.3615-3623.2003
-
Kapikian A Z, Hoshino Y, Chanock R M. Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children[J]. J Infect Dis, 1996, 174(Suppl 1): S65-72.
-
Koutsky L A, Ault K A, Wheeler C M. A controlled trial of a human papillomavirus type 16 vaccine[J]. N Engl J Med, 2002, 347(21): 1645-1651. doi: 10.1056/NEJMoa020586
-
Kumar M, Carmichael G G. Antisense rna: Function and fate of duplex rna in cells of higher eukaryotes[J]. Microbiol Mol Biol Rev, 1998, 62(4): 1415-1434.
-
Lamm M E. Interaction of antigens and antibodies at mucosal surfaces[J]. Annu Rev Microbiol, 1997, 51(): 311-340. doi: 10.1146/annurev.micro.51.1.311
-
Lau Y F, Tang L H, Ooi E E. A tlr3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic[J]. Vaccine, 2009, 27(9): 1354-1364. doi: 10.1016/j.vaccine.2008.12.048
-
Lau Y F, Tang L H, Mccall A W. An adjuvant for the induction of potent, protective humoral responses to an h5n1 influenza virus vaccine with antigen-sparing effect in mice[J]. J Virol, , 84(17): 8639-8649. doi: 10.1128/JVI.00596-10
-
Lau Y L, Peiris J S. Pathogenesis of severe acute respiratory syndrome[J]. Curr Opin Immunol, 2005, 17(4): 404-410. doi: 10.1016/j.coi.2005.05.009
-
Leung W K, To K F, Chan P K. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection[J]. Gastroenterology, 2003, 125(4): 1011-1017. doi: 10.1016/j.gastro.2003.08.001
-
Levine M M. Immunization against bacterial diseases of the intestine[J]. J Pediatr Gastroenterol Nutr, 2000, 31(4): 336-355. doi: 10.1097/00005176-200010000-00003
-
Li L, Shen E-X, Huang J. Pika adjuvant induces the immune responses in mouse in vitro and in vivo[J]. Chin J Immunol, 2006, 22(11): 983-986.
-
Li P-P, Yang X-M, Fang Z-Z. Preparation of inactivated sars vaccine[J]. Chin J Biologicals, 2005, 18(): 390-393.
-
Lin H X, Gontier C, Saron M. A new immunostimulatory complex (pickca) in experimental rabies: Antiviral and adjuvant effects[J]. Arch Virol, 1993, 131(3-4): 307-319. doi: 10.1007/BF01378634
-
Lin M, Tseng H-K, Trejaut J-A. Association of HLA class I with severe acute respiratory syndrome coronavirus infection[J]. BMC Med Genet, 2003, 4(): 9-.
-
Luo J, Gai W, Lei L. Prokaryotic expression of the sars-cov spike protein and preliminary studies on its mucosal immune response[J]. J Wuhan Univ (Natural Science), 2006, 52(6): 733-738.
-
Mazanec M B, Kaetzel C S, Lamm M E. Intracellular neutralization of virus by immunoglobulin a antibodies[J]. Proc Natl Acad Sci USA, 1992, 89(15): 6901-6905. doi: 10.1073/pnas.89.15.6901
-
Modlin J F. Poliomyelitis in the united states: The final chapter? JAMA[J]. JAMA, 2004, 292(14): 1749-1751. doi: 10.1001/jama.292.14.1749
-
Neutra M R, Kozlowski P A. Mucosal vaccines: The promise and the challenge[J]. Nat Rev Immunol, 2006, 6(2): 148-158. doi: 10.1038/nri1777
-
Qu X X, Hao P, Song X J. Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy[J]. J Biol Chem, 2005, 280(33): 29588-29595. doi: 10.1074/jbc.M500662200
-
Sambrook J F E, Maniatis T. 1989. Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press.
-
Shen E, Li L, Li L. Pika as an adjuvant enhances specific humoral and cellular immune responses following the vaccination of mice with hbsag plus pika[J]. Cell Mol Immunol, 2007, 4(2): 113-120.
-
Sloat B R, Cui Z. Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities[J]. Pharm Res, 2006, 23(6): 1217-1226. doi: 10.1007/s11095-006-0206-9
-
Subbarao K, Mcauliffe J, Vogel L. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice[J]. J Virol, 2004, 78(7): 3572-3577. doi: 10.1128/JVI.78.7.3572-3577.2004
-
Takao S I, Kiyotani K, Sakaguchi T. Protection of mice from respiratory sendai virus infections by recombinant vaccinia viruses[J]. J Virol, 1997, 71(1): 832-838.
-
Takasuka N, Fujii H, Takahashi Y. A subcutaneously injected uv-inactivated sars coronavirus vaccine elicits systemic humoral immunity in mice[J]. Int Immunol, 2004, 16(10): 1423-1430. doi: 10.1093/intimm/dxh143
-
Tang J W, To K F, Lo A W. Quantitative temporal-spatial distribution of severe acute respiratory syndrome-associated coronavirus (sars-cov) in post-mortem tissues[J]. J Med Virol, 2007, 79(9): 1245-1253. doi: 10.1002/(ISSN)1096-9071
-
Ter Meulen J, Bakker A B, Van Den Brink E N. Human monoclonal antibody as prophylaxis for sars coronavirus infection in ferrets[J]. Lancet, 2004, 363(9427): 2139-2141. doi: 10.1016/S0140-6736(04)16506-9
-
To K F, Lo A W. Exploring the pathogenesis of severe acute respiratory syndrome (sars): The tissue distribution of the coronavirus (sars-cov) and its putative receptor, angiotensin-converting enzyme 2 (ace2)[J]. J Pathol, 2004, 203(3): 740-743. doi: 10.1002/(ISSN)1096-9896
-
Underdown B J. 2005. Parenteral immunization induces mucosal protection: A challenge to the mucosal immunity paradigm, In: Mucosal immunology (Mestecky J, Bienenstock J, Lamm M E, et al. ed. ), 3rd edition. Burlington: Elsevier Academic Press. Vol 1, p831-840.
-
Verdijk R M, Mutis T, Esendam B. Polyriboinosinic polyribocytidylic acid (poly(i:C)) induces stable maturation of functionally active human dendritic cells[J]. J Immunol, 1999, 163(1): 57-61.
-
Xiao B G, Link H. Mucosal tolerance: A two-edged sword to prevent and treat autoimmune diseases[J]. Clin Immunol Immunopathol, 1997, 85(2): 119-128. doi: 10.1006/clin.1997.4432
-
Yan H, Lamm M E, Bjorling E. Multiple functions of immunoglobulin a in mucosal defense against viruses: An in vitro measles virus model[J]. J Virol, 2002, 76(21): 10972-10979. doi: 10.1128/JVI.76.21.10972-10979.2002
-
Yang Y L, Reis L F, Pavlovic J. Deficient signaling in mice devoid of double-stranded rna-dependent protein kinase[J]. Embo J, 1995, 14(24): 6095-6106.